OOIR: Observatory of International Research

Papers

(The H4-Index of Europace is 54. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used?	603
Examination of pituitary adenylate cyclase-activating polypeptide (PACAP) in patients with atrial fibrillation undergoing pulmonary vein isolation	399
Impact of pulsed-field ablation on kidney function	293
The effect of virtual reality on anxiety reduction in supraventricular tachycardia ablation: prospective study	278
Early detection of fluid retention with a multisensory algorithm in chronic heart failure patients	231
Single-chamber versus dual-chamber pacing: real world data from the German national VIDEO project	215
Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial	209
Pulmonary vein isolation with the novel radiofrequency balloon catheter: predictors of single-shot isolation	164
Coronary sinus cannulation as real time anatomical landmark to facilitate left bundle branch area pacing	149
A leadless ventricular pacemaker providing atrioventricular synchronous pacing in the real-world setting: acute results from the Micra AV post-approval registry	142
Serial arterial blood gas monitoring during deep sedation for left atrial ablation procedures: a retrospective cohort study	138
CRT with triple fusion: results of the multicentric, randomized, doble-blinded CRUSTY trial	124
CIED replacement optimization: feasibility, safety and acceptability of day surgery setting for CIED replacement	116
Extended use of preprocedural data to detect expiratory airflow limitation in patients with atrial fibrillation scheduled for ablation	116
Pulsed field ablation of the left common pulmonary vein: a new single-shot solution?	111
New insights from repeated extra-cardiac vagal nerve stimulation after recent successful cardioneuroablation in high risk patients with vagally-mediated bradyarrhythmias	110
Analysis of mitral isthmus ablation in patients undergoing a second ablation procedure after atrial fibrillation ablation with electroporation vs. radiofrequency	110
New onset, recurrence and progression of atrial fibrillation after cardiac surgery during 2.5 years of continuous rhythm monitoring	108
The new "olive strategy" for pulsed field ablation of atrial fibrillation: procedural data and early follow-up	105
Volumetric quantification of epicardial fat using semiautomated atrial CT segmentation in patients with atrial fibrillation: the Prospective AFAT study	103
High efficacy and safety of endocardial pulsed electrical field ablation via contact force-controlled catheters for mitral isthmus ablation	94
Implementation of near zero fluoroscopy in supraventricular tachycardia ablation procedures: a single center experience	94
Computed tomography as a predictive tool for ventricular tachycardia	85
Adherence to a mobile health-based atrial fibrillation screening program: a subanalysis from STROKESTOP I and II	82
Rhythm matters: sinus and pace rhythm map significantly differ in endo/epicardial 3D electroanatomic mapping	80

Prevalence and risk factors of pre-procedural left atrial thrombus in patients undergoing pulmonary vein isolation	78
Ablation for idiopathic ventricular arrhythmias using focal pulsed field ablation	76
Sudden cardiac death and atrial depolarization in coronary artery disease—Authors’ reply	74
Preclinical evaluation of safety and efficacy of the Coherent Sine-Burst Electroporation (CSE) ablation system in a chronic porcine beating heart model	72
Management of modifiable risk factors and comorbidities in atrial fibrillation: suggestions for improvement from a patient perspective	71
Long-term effects of catheter ablation versus antiarrhythmic drugs on health-related quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial revisited	71
LINAC-Based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly: a prospective phase II trial	69
Early vs. delayed vt ablation in patients with ischemic cardiomyopathy	68
Atrioventricular nodal reentrant tachycardia ablation (avnrt), a female disease. insights from the german ablation registry	66
Clinical validation of an artificial intelligence algorithm offering automated corrected QT-interval measurements from a single lead electrocardiogram	65
Left atrial low-voltage areas, but not volume, predict the recurrence of atrial fibrillation in repeat ablation procedures	65
Cardiac magnetic resonance - aided ventricular tachycardia substrate ablation	65
Stiff but keeping the beat: catheter ablation for atrial fibrillation in cardiac amyloidosis and sarcoidosis	63
Artificial intelligence assisted QT interval measurement in 12-lead-ECGs	63
First experience of focal pulsed field ablation for premature ventricular contractions	63
Hemolysis after atrial fibrillation ablation conducted with a new point-by-point pulsed field ablation device	62
Different approaches to atrial fibrillation ablation in heart failure patients: temporal trends and clinical outcomes	62
Optimisation of decrementing evoked potential mapping for functional substrate identification in ischaemic ventricular tachycardia ablation	61
Scar architecture determinants of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study	61
Pacemaker dependency after Cox Maze procedure concomitant with cardiac surgery, The road between Scylla and Charybdis	60
MicroPort CRM considerations on Vega pacing lead performance	59
Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion	58
Conduction system pacing vs biventricular pacing in patients with left bundle branch block and resynchronization therapy indication. CONSYST-CRT trial secondary findings	56
Ventricular pre-excitation in young patients: long term follow-up and natural history in a contemporary cohort	56
Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation	56
Genetic and clinical risk factors for stroke recurrence with different impact by assessment age: data from the UK Biobank	55
Impact of additional pulsed field ablation in unsuccessful radiofrequency linear lesions -acute and chronic data	54
Long-term heart failure improvement after catheter ablation of persistent atrial fibrillation in heart failure with preserved, mildly reduced and reduced ejection fraction	54
Left atrial epicardial adipose tissue: correlation to left atrial fibrosis and arrhythmia recurrence post atrial fibrillation ablation	54